Introduction
The Wnts comprise a large family of secreted lipid-modified glycoproteins that have a variety of activities during embryonic development and promote tissue homeostasis in the adult (Klaus and Birchmeier, 2008) . They are particularly important in the development of the nervous system where they participate in several morphogenetic events including neural tube closure, formation of specific brain structures, as well as the induction and migration of neural crest cells (Ciani and Salinas, 2005; Malaterre et al., 2007) . Wnts also stimulate axonal remodeling, pathfinding, dendritic arborization, and synaptogenesis (Salinas and Zou, 2008) .
Several Wnt signaling mechanisms have been implicated in neurite outgrowth (Ciani and Salinas, 2005; Endo and Rubin, 2007; Sánchez-Camacho and Bovolenta, 2009 ). They are mediated by various Wnts and the Frizzled seven-pass transmembrane Wnt receptors or the atypical tyrosine kinase Wnt receptor, Ryk/ Derailed (Yoshikawa et al., 2003; Lu et al., 2004; Liu et al., 2005) . Wnt-7a promoted axonal remodeling of mossy fibers in mouse cerebellum by stabilizing microtubules via a mechanism that involved Dishevelled 1 (Dvl-1) and inhibition of glycogen synthase kinase 3 (GSK-3; Krylova et al., 2000; Ciani et al., 2004) .
Activation of Dvl-1, Rac1, and c-Jun N-terminal kinase (JNK) by Wnt-7b stimulated dendritic arborization in hippocampal neurons (Rosso et al., 2005) . Axon specification in hippocampal neurons was induced by Wnt-5a through a process that relied on interaction of Dvl-2 with atypical PKC- (Zhang et al., 2007) , an enzyme that also mediated Wnt-4-dependent extension of commissural axons (Lyuksyutova et al., 2003; Wolf et al., 2008) .
As noted in the previous paragraph, Dvl isoforms contribute to Wnt-dependent neurite outgrowth in a variety of ways. Dvls function as positive effectors in the canonical Wnt/-catenin pathway as well as in the noncanonical planar cell polarity (PCP) and calcium-dependent pathways (Gao and Chen, 2010) . Many of their activities have been associated with specific molecular domains and presumed to be regulated by phosphorylation. Dvls have dozens of potential phosphorylation sites and are substrates for several kinases, including casein kinase 1 (CK1), CK2, and protein kinase C (Wallingford and Habas, 2005) . In particular, several articles suggest a functional connection between CK1 and Dvls (Bryja et al., 2007a,b; .
The CK1 family of evolutionarily conserved serinethreonine kinases consists of seven isoforms in mammals P reviously we determined that Dishevelled-2/3 (Dvl) mediate Wnt-3a-dependent neurite outgrowth in Ewing sarcoma family tumor cells. Here we report that neurite extension was associated with Dvl phosphorylation and that both were inhibited by the casein kinase 1 (CK1) / inhibitor IC261. Small interfering RNAs targeting either CK1 or CK1 decreased Dvl phosphorylation, but only knockdown of CK1 blocked neurite outgrowth. CK1 but not CK1 was detected at the centrosome, an organelle associated with neurite formation. Deletion analysis mapped the centrosomal localization signal (CLS) of CK1 to its C-terminal domain. A fusion protein containing the CLS and EGFP displaced full-length CK1 from the centrosome and inhibited Wnt-3a-dependent neurite outgrowth. In contrast to wild-type CK1, a chimera comprised of the kinase domain of CK1 and the CLS of CK1 localized to the centrosome and rescued Wnt-3a-dependent neurite outgrowth suppressed by CK1 knockdown. These results provide strong evidence that the centrosomal localization of CK1 is required for Wnt-3a-dependent neuritogenesis.
mobility shift of Dvl-2 and Dvl-3 in SDS-PAGE and decreased the recognition of Dvl-2 by mAb 10B5 (Fig. 1) , all signs of Dvl phosphorylation (González-Sancho et al., 2004) . No changes in Dvl mobility or immunoreactivity were seen with Wnt-1 CM. However, TC-32 cells were able to respond to Wnt-1 in other ways, as indicated by the stabilization of -catenin (Endo et al., 2008) . The differential effects of Wnt-3a and Wnt-1 on Dvl phosphorylation suggested a potential connection between these post-translational modifications and Wnt-3a-dependent neurite outgrowth.
CK1 and CK1 both phosphorylate
Dvl-2/3, but only CK1 is required for neurite outgrowth induced by Wnt-3a
A screen of small molecule inhibitors targeting kinases known to phosphorylate Dvls revealed that IC261, a preferential inhibitor of CK1/ (Mashhoon et al., 2000) , blocked Wnt-3a-dependent Dvl-2 phosphorylation and neurite extension. To confirm that CK1 and CK1 were responsible for the Dvl-2 mobility shift, we pretreated TC-32 cells with siRNA reagents directed against CK1 or CK1 alone or in combination before incubation with Wnt-3a. Western blot analysis verified that the siRNA reagents specifically inhibited the expression of the corresponding CK1 isoforms (Fig. 2 A) . Immunoblotting with the Dvl-2 mAb 10B5 showed that knockdown of each CK1 isoform decreased the Wnt-3a-dependent mobility shift and loss of epitope recognition, whereas the simultaneous knockdown of CK1/ had a stronger effect. The CK1/ siRNA reagents also decreased the Dvl-2 mobility shift and enhanced 10B5 cross-reactivity in the absence of added Wnt-3a, implying that in the basal state Dvl-2 was partially phosphorylated by CK1 and CK1 (Fig. 2 A) .
When cells were treated with CK1/ siRNA reagents in the neurite outgrowth assay, we obtained a surprising result. Although CK1 knockdown markedly inhibited Wnt-3a-induced neurite formation (Fig. 2 B) , CK1 knockdown increased neurite formation in the absence of exogenous Wnt-3a, and there was no additional stimulation by Wnt-3a (Fig. 2, B and C). The CK1 requirement was confirmed when neurite outgrowth was rescued by expression of an siRNA-resistant CK1 construct. Simultaneous knockdown of CK1 and CK1 prevented the neurite outgrowth observed when only CK1 expression had been suppressed (Fig. 2, D-F) , further emphasizing the importance of CK1 for neurite formation.
(, , 1, 2, 3, , and ). These enzymes share a highly related kinase domain but differ considerably in the length and sequence of their N-and C-terminal regions. The C-terminal domains have a role in the contrasting activities and regulation of the various isoforms (Graves and Roach, 1995; Gross and Anderson, 1998; Dahlberg et al., 2009 ). CK1 enzymes participate in multiple processes including DNA repair, cell cycle progression, and circadian rhythm (Gross et al., 1997; Lowrey et al., 2000) . All the isoforms except CK1s phosphorylate Dvl in vivo (McKay et al., 2001) . However, accounts of the functional consequences associated with Dvl phosphorylation vary widely. CK1 was initially identified as a positive regulator of the -catenin pathway in Xenopus via a Dvl-dependent mechanism (Peters et al., 1999; Sakanaka et al., 1999) . Another report claimed that CK1-dependent Dvl phosphorylation caused a shift from JNK to -catenin signaling in Drosophila (Cong et al., 2004) . However, others observed that CK1 stimulated PCP signaling (Strutt et al., 2006) , or both PCP and -catenin signaling in Drosophila after Dvl phosphorylation (Klein et al., 2006) . Alternatively, inhibition of CK1/ blocked Wnt-3a-dependent Dvl phosphorylation in a rat dopaminergic cell line, but did not prevent activation of the -catenin pathway (Bryja et al., 2007a) . The same group also documented Wnt-5a-dependent Dvl phosphorylation by CK1/ and linked it to dopaminergic differentiation (Schulte et al., 2005; Bryja et al., 2007b) . Subsequently, they suggested that Dvl phosphorylation by CK1/ triggered a switch from Rac1 activation to stimulation of another noncanonical signaling mechanism (Bryja et al., 2008) .
Previously, we reported that Wnt-3a induced neurite outgrowth in Ewing sarcoma family of tumor (ESFT) cells via a noncanonical mechanism that required Frizzled-3, Dvl-2/3, and JNK activation (Endo et al., 2008) . Now we describe a connection between Dvl phosphorylation and neurite outgrowth. Although CK1 and CK1 both contributed to Dvl phosphorylation, only CK1 was required for Wnt-3a-dependent neurite extension. CK1, but not CK1 was strongly localized to the centrosome, an organelle that functions in neurite formation (de Anda et al., 2005; Higginbotham and Gleeson, 2007) , and displacement of CK1 from the centrosome was associated with inhibition of neurite outgrowth. Moreover, a chimera comprised of the kinase domain of CK1 and the centrosomal localization signal (CLS) of CK1 rescued neurite outgrowth when expression of endogenous CK1 was inhibited by siRNA. These findings demonstrated a surprising difference in function of CK1 and CK1 and established the importance of CK1 centrosomal localization for Wnt-3a-dependent neurite outgrowth.
Results

Dvl-2/3 phosphorylation is associated with
Wnt-3a-dependent neurite outgrowth
Wnt-3a stimulates neurite outgrowth in a variety of ESFT cell lines including TC-32 cells. In contrast, Wnt-1 conditioned medium (CM) failed to elicit neurite outgrowth (Endo et al., 2008) . To investigate differences in the signaling downstream of Wnt-1 and Wnt-3a, we examined dose-dependent changes in Dvl phosphorylation after treatment of TC-32 cells. Wnt-3a CM induced a A weaker signal was detected in the cytoplasm and in neurites (Fig. 3 A) . Analysis of CK1 distribution revealed a diffuse pattern and little colocalization with pericentrin, another centrosomal marker (Fig. 3 B) . To ensure that the contrast in centrosomal localization of CK1 and CK1 was not due to differences in detection conditions, experiments were performed with HeLa cells expressing Myc-tagged CK1 or CK1 and co-stained with Myc and pericentrin antibodies. As in CK1 but not CK1 is strongly localized to the centrosome Because neurite outgrowth and axonal specification are dependent on the activity of the centrosome (de Anda et al., 2005; Higginbotham and Gleeson, 2007) , we examined the centrosomal distribution of CK1 and CK1 in TC-32 cells. Confocal microscopy of methanol-fixed cells showed an intense signal for CK1 that colocalized with the centrosomal marker -tubulin (Fig. 3 A) . TC-32 cells, only CK1 colocalized with the centrosomal marker (Fig. 4) .
To further evaluate the centrosomal distribution of CK1 and CK1, Pearson's correlation coefficient was calculated for each of the Myc-tagged CK1 proteins and centrosomal pericentrin in transiently transfected TC-32 cells (Zinchuk et al., 2007) . The correlation coefficient for CK1 (0.466 ± 0.147, n = 13) was significantly greater (P < 0.001) than that for CK1 (0.195 ± 0.073, n = 12), reinforcing the conclusion that CK1 exhibited a much stronger association with the centrosome.
Centrosomal localization signal of CK1 is in the C-terminal domain
CK1 and CK1 are 87% and 97% identical in their N-terminal and kinase domains, respectively, but only 55-56% identical in their C-terminal domains (Fig. 4 A) . We hypothesized that the C-terminal sequences accounted for the differences in their centrosomal distribution. To test this idea, colocalization experiments were performed in HeLa cells that expressed Myc-tagged wild-type CK1 isoforms or chimeras in which the C-terminal domains had been interchanged. Co-staining with antibodies to Myc and pericentrin demonstrated that only wild-type CK1 and the chimera containing its C-terminal domain (CT) showed a clear association (Fig. 4 B) . This suggested that CT was required for centrosomal distribution, a conclusion that was confirmed when a CK1 derivative lacking CT failed to localize to the centrosome (Fig. S1 ). To determine whether CT was sufficient for centrosomal localization, CT sequence was linked to cDNA encoding enhanced GFP (EGFP). Transient expression in HeLa cells followed by confocal microscopy revealed that CT-EGFP bound to the centrosome, whereas EGFP did not (Fig. 4 C) . A similar construct containing the C-terminal domain of CK1 exhibited weaker centrosomal localization (Fig. 4 C) . Taken together, these findings established that CT was both necessary and sufficient for CK1 binding to the centrosome.
To map the CLS within CT, a series of CT-EGFP truncation mutants were generated and their colocalization with pericentrin was examined in transiently transfected HeLa cells ( Fig. 5 and Fig. S2 ). A strong centrosomal signal was seen in >70% of cells expressing the mutant lacking residues 365-415 (CT(278-364)-EGFP). The derivative lacking residues 326-415 (CT(278-325)-EGFP) also localized to the centrosome in a large majority of cells, although the signal intensity was diminished. Further deletion of C-terminal sequences resulted in a progressively decreasing proportion of cells in which co-staining with pericentrin was observed. A complementary construct lacking residues 278-325 exhibited little association with the centrosome. These results demonstrated that residues 278-325 were necessary but not sufficient for a strong association with the centrosome. We concluded that the CLS was comprised of residues 278-364. Interestingly, this region contains most of the evolutionarily conserved differences between CK1 and CK1 (Fig. S3 ).
EGFP fusion proteins containing an intact CLS displaced full-length CK1 from the centrosome and blocked neurite outgrowth
To test the functional relevance of centrosomal CK1, we first determined that EGFP derivatives containing the CLS could prevent the accumulation of CK1 at the centrosome. Myc-tagged CK1 was required in these experiments because the antibody used to detect endogenous CK1 cross-reacts with the C-terminal domain. CT/EGFP and CT(278-364)-EGFP each inhibited the centrosomal localization of Myc-tagged CK1 when the constructs were coexpressed in TC-32 cells (Fig. 6, A and B) . Semi-quantitative analysis indicated that the centrosomal staining pattern was absent from at least 70% of the 30 cells examined (Fig. 6 B) . In contrast, when cells coexpressed a truncation mutant lacking approximately half of the CLS, CT(278-325)-EGFP, only 10% lacked the centrosomal staining pattern (Fig. 6 B) . EGFP also did not impede the centrosomal distribution of Myc-CK1 (Fig. 6, A and B) . Moreover, CT/EGFP had little effect on CK1 centrosomal localization, even when CT/EGFP was detected at the centrosome (Fig. 6, A and B) . Immunoblotting confirmed that the failure to block centrosomal localization was not due to low levels of fusion protein expression (Fig. 6, C and D) .
Expression of CT-EGFP in TC-32 cells dramatically inhibited the neurite outgrowth normally elicited by Wnt-3a (Fig. 6 E) . Alternatively, CT-EGFP and EGFP did not block the response to Wnt-3a even though the proteins were expressed at higher levels than CT-EGFP (Fig. 6 , E and F). These results support the idea that the centrosomal localization of CK1 is important for Wnt-3a-dependent neurite outgrowth.
Contrasting activity of CK1 and CK1 in neurite outgrowth is directly linked to centrosomal localization
To further address the potential relevance of centrosomal CK1 for neurite outgrowth, we investigated the activity of a CK1 derivative that contained the CLS of CK1 in place of its own C-terminal domain. As with the CK1/CT chimera (Fig. 4 B) , this protein showed a strong centrosomal staining pattern (Fig. S4) . Neurite extension after Wnt-3a administration was abrogated when TC-32 cells were pretreated with CK1 siRNA targeting a 3UTR sequence and rescued by the expression of full-length CK1 (Fig. 7, A and B) . Although neurite outgrowth was not maintained by the expression of full-length CK1, it was rescued by mCK1/CT(278-364) (Fig. 7, A and B) . Thus, the addition of sequence to CK1 that anchored it like CK1 to the centrosome was sufficient to enable Wnt-3a-dependent neurite outgrowth.
Discussion
The current study is the first to demonstrate a critical role for CK1 in neurite formation. Knockdown of CK1 expression by siRNA blocked Wnt-3a-dependent neurite outgrowth in TC-32 cells, and the CK1 requirement was confirmed when transfection with an siRNA-resistant CK1 cDNA restored neuritogenesis. Moreover, we determined that the centrosomal localization of CK1 is important for neurite extension. Using CK1/ chimeras and a series of CK1/EGFP fusion proteins we identified the CLS within the CK1 C-terminal domain. Only EGFP fusion proteins containing this CLS displaced full-length CK1 from the centrosome, mimicking results obtained with corresponding Semi-quantitative analysis was based on the intensity of EGFP signal that colocalized with pericentrin relative to EGFP signal elsewhere in the cell. Intense signal that colocalized with pericentrin was scored as ++ (black), colocalizing signal intensity comparable to that seen elsewhere in the cell was + (dark gray), weak signal was +/ (light gray), and no signal was  (white). The bar graph displays the percentage of cells in each category for all the fusion proteins. See also Fig. S2. system not only is the requirement of CK1 for Wnt-3a-dependent neurite outgrowth significant, the stimulation of neurite extension after CK1 siRNA treatment also is noteworthy. Apparently CK1 has an inhibitory effect on neurite outgrowth, perhaps by competing with CK1 for interaction with critical substrates. In this regard, we propose that their differential localization to the centrosome is critical: CK1 elsewhere in the cell could prevent substrate access to CK1 at the centrosome where phosphorylation presumably is crucial for neuritogenesis. Consistent with this view, CK1 and Dvl-2/3 were required for neurite outgrowth induced by CK1 siRNA knockdown (Fig. 2,  D-F and Fig. S5 ).
The lack of substantial centrosomal localization by CK1 reported in this paper differs from an earlier finding in which both CK1 and CK1 were identified at the centrosome (Milne et al., 2001) . Moreover, in that article the kinase domain was alleged to be required for the centrosomal distribution. We believe our divergent results are attributable to differences in technique: the former study relied on conventional immunofluorescent microscopy rather than confocal microscopy and therefore may not have had sufficient resolution to draw definitive conclusions about the centrosomal distribution. Subsequently, the same investigators demonstrated that CK1 and CK1 associated with CLS/EGFP fusion proteins that displaced cyclins A and E from the centrosome (Matsumoto and Maller, 2004; Pascreau et al., 2010) . Displacement of CK1 from the centrosome was associated with inhibition of Wnt-3a-dependent neurite outgrowth, whereas expression of a similar fusion protein lacking the CLS or EGFP alone did not block neurite extension. Prior work demonstrated the importance of cell membrane or nuclear localization for the function of specific CK1 isoforms and implicated the C-terminal domain in this spatial regulation (Gross and Anderson, 1998; Robinson et al., 1999; Babu et al., 2002) . In the present study, the C-terminal domain again was shown to specify a functionally important subcellular distribution, as the centrosomal localization of CK1 was pivotal for Wnt-3a-dependent neurite outgrowth.
Our study revealed a surprising functional difference between CK1 and CK1. Typically, they have been described as having similar or redundant activities, reflecting the 97% homology of their kinase domains (Knippschild et al., 2005) . Both CK1 and CK1 contribute to the control of circadian rhythm (Lowrey et al., 2000; Lee et al., 2009) , although recent studies with gene knockout mouse models and selective inhibitors for each kinase suggest that CK1 has a stronger effect (Etchegaray et al., 2009; Meng et al., 2010) . In our experimental will address the potential activity of CK1 in such centrosomal processes. In this paper, we established a key role for CK1 in Wnt-3a-dependent neurite outgrowth that underscores the importance of its localization at the centrosome.
Materials and methods
Recombinant protein and chemicals
Recombinant Wnt-3a was purchased from R&D Systems. Wnt-1 and Wnt-3a conditioned media (CM) were prepared as described previously (Endo et al., 2008) . In brief, Wnt-1 CM was collected from a Wnt-1 stably transfected Rat-2 fibroblast line (kindly provided by Anthony Brown, Cornell Medical Center, New York, NY) after 72 h incubation in serum-free RPMI 1640 medium. Wnt-3a CM was obtained from a Wnt-3a stably transfected L929 clonal line after 72 h incubation in serum-free EMEM supplemented with nonessential amino acids, 2 mM l-glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 µg/ml streptomycin. IC261 was purchased from EMD. Geneticin was obtained from Invitrogen.
Antibodies and reagents used for immunostaining
Alexa Fluor 488 phalloidin, Alexa Fluor 568 phalloidin, Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 488 goat anti-rabbit IgG, Alexa Fluor 568 goat anti-rabbit IgG, and Alexa Fluor 660 goat anti-mouse IgG were from Invitrogen. Mouse anti-CK1 antibody 128A was kindly provided by Eli Lilly. Mouse anti-CK1 was from BD. Rabbit anti-pericentrin antibody and mouse anti-pericentrin antibody were from Abcam. 4,6-diamidino-2-phenylindole (dihydrochloride; DAPI) and rabbit anti--tubulin antibody were from SigmaAldrich. Rabbit anti-Myc antibody was from Cell Signaling Technology.
Antibodies used for Western blotting
Mouse anti-CK1 (cat. no. sc-55553), mouse anti-Dvl-2 (10B5), rabbit antiDvl2 (H-75), mouse anti-Dvl-3 (4D3), and mouse anti-HSP70 antibodies were from Santa Cruz Biotechnology, Inc. Mouse anti-Myc antibody was from Invitrogen. Mouse anti-CK1 antibody was from BD. Mouse anti-GFP was from Covance.
AKAP450 via the kinase domain (Sillibourne et al., 2002) . Although AKAP450 localizes to the centrosome, it also is found at other sites such as the Golgi (Schmidt et al., 1999; Takahashi et al., 1999) , where CK1 and CK1 have been detected (Milne et al., 2001) . A recent report about CDK5RAP2 showed that it also localizes to the centrosome and Golgi, and that binding to AKAP450 was responsible for its Golgi but not centrosomal distribution (Wang et al., 2010) . We suggest that AKAP450 binding to CK1 and CK1 may contribute to their Golgi distribution, whereas other binding partners are necessary for the centrosomal localization of CK1.
The centrosomal distribution of CK1 has potential significance that goes beyond neurite outgrowth. Detection of CK1 at the mitotic spindle and induction of cytokinesis defects, mitotic arrest, centrosomal amplification, and the formation of multipolar spindle structures by IC261 suggest a broader role for CK1 in centrosomal structure and function (Behrend et al., 2000; Stöter et al., 2005) . Although a functional connection between CK1 and Dvl has not been established in this context, a recent article demonstrated the presence of Dvl-2 at the mitotic spindle and a role in cell cycle regulation (Kikuchi et al., 2010) . Dvl also contributes to the formation of motile cilia by facilitating the docking and planar polarization of the centrosomally derived basal bodies (Park et al., 2008) . Furthermore, other Wnt pathway components, Axin2/conductin and -catenin, have been identified at the centrosome and participate in centrosomal separation (Bahmanyar et al., 2008; Hadjihannas et al., 2010) , a process that is disrupted by IC261 (Stöter et al., 2005) . Future investigation Figure 7 . mCK1/CT(278-364) rescued Wnt-3a-dependent neurite outgrowth otherwise inhibited by CK1 siRNA. (A) Wnt-3a-dependent neurite outgrowth in TC-32 cells treated with hCK1 siRNA targeting 3-UTR sequence and transiently transfected with empty vector (pcDNA3.3 Ctl.) or construct expressing mouse full-length CK1, full-length CK1, or chimera consisting of CK1 N-terminal and kinase domains plus residues 278-364 from mouse CK1 C-terminal domain. The presence of neurites was quantified in 30 cells expressing Myc-tagged CK1 protein for each treatment group. Data are from one of two experiments with similar results. (B) Immunoblot analysis of ectopically expressed Myc-tagged CK1 proteins, endogenous CK1, and HSP70 in the neurite outgrowth experiment. Results illustrate the efficacy and specificity of knockdown with siRNA directed against human CK1 3-UTR sequence.
Combined transfection of DNA and siRNA (rescue experiment) Cotransfection of pcDNA3.3 6x myc-mCK1, 6x myc-mCK1, or 6x myc mCK1/CT (278-364) constructs and siRNA targeting hCK1 3UTR sequence were performed with Amaxa system or GenMute (SignaGen). For Amaxa transfection, 10 6 cells were resuspended with 2 µg DNA and 200 pmol of siRNA, and placed in 6-well and 24-well plates. 72 h later, cells in 6-well plate were harvested for Western blotting, and cells placed in 24-well plates were treated with 100 ng/ml recombinant Wnt-3a for 3 h and fixed with formaldehyde to analyze neurite outgrowth. For GenMute, TC-32 cells were plated on the day before transfection on 6-well and 24-well plates. Cells were 50-60% confluent on the day of transfection. 0.5 µg DNA and 5 pmol of siRNA were used for 6-well plate, 0.25 µg DNA and 2.5 pmol siRNA were used for 24-well plate. 48 h later, cells in 6-well plates were harvested for immunoblotting, cells in 24-well plates were treated with 100 ng/ml recombinant Wnt-3a for 3 h, and fixed with formaldehyde to analyze neurite outgrowth.
Lentiviral expression
Lentiviral particles were produced by transient transfection of HEK293T cells. 2 d after transfection, the cell culture medium was harvested and concentrated 10-fold with Amicon Ultra-15 (Millipore) and stored at 80°C. On the day before transfection, HeLa cells were plated in a 6-well plate at a density that reached 80-90% confluency the next day. On the day of transfection, 0.2 ml of concentrated lentiviral particle was added to each well filled with 1 ml of complete growth medium and 8 µg/ml of polybrene (Millipore). 24 h later the medium was replaced with fresh complete medium without polybrene. After another 24 h geneticin was added to cell culture medium (400 µg/ml) to obtain stable transfectants. Fresh complete medium supplemented with geneticin was provided every 2 d. 1 wk later cells were subjected to Western blotting to verify recombinant protein expression.
Immunofluorescent analysis TC-32 or HeLa cells were seeded on 12-mm-diam glass coverslips (Thermo Fisher Scientific) in complete growth medium. For TC-32 cells, collagencoated coverslips were used. Depending on the combination of antibodies and reagents, different fixatives were used (Table S1 ). For methanol (MeOH) fixation, cells were first washed once with PBS, then with PHEM (60 mM Na-Pipes, 25 mM Na-Hepes, 10 mM Na-EGTA, and 2 mM MgCl 2 , pH 6.9), followed by treatment with PHEM containing 0.19 M NaCl, 1% Saponin, 10 µM Taxol, and 0.1% DMSO for 5 min at room temperature (RT) to extract and stabilize tubulin. Extracted cultures were immersed in MeOH at 30°C for 10 min, rehydrated by rinsing in PBS three times, and treated with blocking solution (5% BSA in PBS) for 30 min at 37°C. Primary antibody/antibodies was/were added with 2.5% BSA in PBS, and cell samples were incubated for 60 min at 37°C or overnight at 4°C. After washing three times with PBS, cell samples were incubated with the secondary antibody reagent(s) and DAPI with 2.5% BSA in PBS for 45 min at RT. After washing three times with PBS, coverslips were mounted on glass slides (VWR Scientific) using ProLong Gold Antifade reagent (Invitrogen). Formaldehyde fixation was performed as described previously (Endo et al., 2008) . In brief, cells were fixed with freshly prepared 3.7% formaldehyde for 15 min at RT and permeabilized with 0.1% Triton X-100 in PBS for 5 min. After blocking with 5% BSA in PBS for 1 h at RT, primary antibody/antibodies was/were added with 2.5% BSA in PBS, and cell samples were incubated for 60 min at 37°C or overnight at 4°C, followed by the same procedure used for the MeOH fixation method described above.
Cell imaging
Fluorescent images were collected with a laser-scanning confocal microscope (510 LSCM; Carl Zeiss, Inc.), using a 63x objective (Carl Zeiss, Inc.) . Zeiss LSM Image Browser version 4.0.0.157 was used for image processing, and composite figures were prepared with Adobe Photoshop CS2 v9.0.2 (Adobe Systems, Inc.).
Quantitative colocalization analysis
To further examine the colocalization of Myc-tagged CK1 and CK1 with pericentrin at the centrosome in TC-32 cells, Pearson's correlation coefficient was calculated with Imaris x64 (v7.0.0) image visualization software (Bitplane, Inc.).
Quantitative analysis of neurite outgrowth Stimulation of neurite outgrowth was monitored as described previously (Endo et al., 2008) .
Recombinant DNA pCS2+ myc-tagged hCK1 and hCK1. pCS2+ 6x myc-hCK1 and pCS2+ hCK1 were gifts from Dr. David Virshup (Institute of Medical Biology, Singapore). 6x myc tag sequence excised from pCS2+ 6x myc-hCK1 with ClaI and StuI was inserted upstream of hCK1 to obtain myc-tagged CK1 construct.
Lentiviral expression constructs. Four lentiviral constructs, pCMV12 6x myc-tagged mouse CK1, CK1, CK1/ (CK1 1-277/CK1 278-416), and CK1/ (CK1 1-277/CK1 278-415) were generated. First, entry clones were constructed by overlap extension PCR using cDNA clones purchased from Thermo Fisher Scientific. Lentiviral expression clones were constructed using Multisite Gateway recombinational cloning to link a promoter to the gene of interest. The backbone vector is a second-generation lentiviral vector based on the pFUFW backbone.
pcDNA3.3 constructs. pcDNA3.3 6x myc-mCK1 and 6x myc-mCK1 were generated by TOPO cloning of PCR products amplified from the lentiviral constructs pCMV12 6x myc mCK1 and 6x myc mCK1, respectively. PCR products (amplified with Expand High Fidelity PLUS PCR system; Roche) were cloned into pcDNA3.3 TOPO vector (Invitrogen). Similarly, pcDNA3.3 6x myc-mCK1/ was generated from lentiviral vector pCMV12 6x myc mCK1/, and used as a PCR template to generate deletion mutant 6x myc-mCK1/CT (278-364). The PCR product (6x myc-mCK/CT 278-364) was cloned into pcDNA3.3 TOPO vector. pcDNA3.3 6x mycmCK1-CT and pcDNA3.3 6x myc-mCK1-CT were obtained by TOPO cloning of PCR products amplified from the corresponding pcDNA3.3 fulllength CK1 constructs, in each case amplifying codons 1-277 of the CK1 isoform coding sequence.
EGFP fusion constructs. To generate CT-EGFP, the construct containing the C-terminal domain of mouse CK1 linked to EGFP, the CT region (278-415) was PCR amplified from mouse CK1 (entry clone used for lentiviral expression construct) and subcloned into pEGFP-N1 (Takara Bio Inc.). A forward primer containing XhoI site at the flanking region, and a reverse primer containing EcoRI site at the flanking region were used to amplify CT. Both PCR product and pEGFP-N1 were digested with XhoI and EcoRI, ligated, and transformed. Deletion mutants were generated by PCR amplification (Expand Long Template PCR system; Roche). Using EcoRI-digested CT-EGFP as a PCR template, PCR products were amplified with corresponding reverse primers, and one common forward primer, all of them containing EcoRI site at the flanking region. PCR products were digested with EcoRI, ligated, and transformed. A similar approach was used to generate CT-EGFP, as CT (278-416) was amplified from the mouse CK1 entry clone and subcloned into pEGFP-N1. The fidelity of all the constructs generated in this study was verified by DNA sequence analysis in the DNA Sequencing MiniCore Facility at the National Cancer Institute (Bethesda, MD).
Cell culture
The ESFT cell line TC-32 was maintained and plated on cell culture dishes, cluster plates, or glass coverslips that had been precoated with type I collagen solution (Sigma-Aldrich) as described previously (Endo et al., 2008) . HeLa cells were maintained in DME (Invitrogen) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin in a 5% CO 2 humidified 37°C cell culture incubator.
siRNA transfection Double-stranded siRNA reagents directed against CK1 and CK1 were purchased from Thermo Fisher Scientific. CK1 siRNA specifically targeting 3UTR sequence was purchased from QIAGEN. Luc siRNA (target sequence: 5-CGUACGCGGAAUACUUCGA-3) was synthesized by Thermo Fisher Scientific.
siRNA transfection experiments in TC-32 cells were performed with the Amaxa system according to the manufacturer's protocol, using 200 pmol of siRNA/10 6 cells. The effects of siRNA treatment were analyzed 48 h after transfection. Immunoblotting To detect CK1, CK1, and Dvl, 80-90% confluent monolayers of TC-32 cells that had been seeded in 6-or 12-well cell culture plates were serum starved overnight. For immunoblot analysis to verify siRNA knockdown of endogenous proteins, TC-32 cells transfected with siRNA were seeded in 6-or 12-well cell culture plates and harvested 48 h after transfection. After incubation for the indicated time, cells were rinsed twice with PBS, lysed with buffer (50 mM Hepes, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 mM sodium pyrophosphate, 50 mM NaF, 1 mM sodium vanadate, 10 µg/ml aprotinin, 10 µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride), and processed for SDS-PAGE and Western blot analysis as described previously (Endo et al., 2008) . In brief, cell lysates were clarified by centrifugation and protein concentration was determined with Protein Assay reagent (Bio-Rad Laboratories). For all immunoblotting, 30 µg of protein was loaded per lane in 10% or 4-20% polyacrylamide Tris-glycine gels. After SDS-PAGE, the proteins were transferred to Immobilon P membrane (Millipore), which was blocked with 5% milk, incubated with primary antibody overnight at 4°C, and subsequently incubated with horseradish peroxidase-labeled secondary antibody. The proteins were visualized with SuperSignal Femto Chemiluminescent reagents (Thermo Fisher Scientific) and BioMax film (Kodak).
DNA transfection
Statistical analysis
The significance of differences in data obtained from neurite outgrowth assays was determined with Student's t test. The differences were considered to be significant when the P value was less than 0.05. Fig. S1 shows immunofluorescent staining of TC-32 and HeLa cells transiently expressing Myc-tagged mouse CK1 or CK1 lacking their respective C-terminal domains. Fig. S2 illustrates the rating system used in Fig. 5 B to analyze the centrosomal distribution of CT-EGFP. Fig. S3 shows the centrosomal localization signal of CK1 and the C-terminal ends of various deletion constructs. Fig. S4 shows the centrosomal localization of mCK1/CT(278-364). Fig. S5 shows that Dvl-2/3 siRNA blocked neurite outgrowth induced by CK1 siRNA. Table S1 provides a summary of conditions (antibodies, other reagents, fixation procedure) used for cell staining in various experiments. Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201011111/DC1.
Online supplemental material
